...
机译:最低临床重要差异分析在CIDP证实IgPro10的功效:第一次试验
CSL Behring LLC, King Of Prussia, PA USA;
Philipps Univ, Dept Neurol, Marburg, Germany;
Spaarne Hosp, Spaarnepoort 1, NL-2134 TM Hoofddorp, NetherlandsAZ St Lucas, Ghent, BelgiumSamodzielny Publ Szpital Klin, Lublin, PolandCSL Behring GmbH, Marburg, GermanyDolnoslaski Szpital Specjalisty, Wroclaw, PolandHop La Pitie Salpetriere, Reference Ctr Rare Neuromuscular Dis, Paris, FranceUniv Helsinki, Dept Neurol, Cent Hosp, Helsinki, FinlandUniv Klinikum Wurzburg, Dept Neurol, Wurzburg, GermanyUZ Leuven, Leuven, Belgium;
Trials; Chronic Inflammatory Demyelinating Polyradiculoneuropathy;
机译:209 CONFIRMING PHASE III CLINICAL TRIAL TO STUDY THE EFFICACY OF A Pperiod;Aperiod;Fperiod; ANTAGONISTcomma; BN 52021 lsqb;BNrsqb;comma; IN REDUCING MORTALITY OF PTS WITH SEVERE GRAMhyphen;NEGATIVE SEPSIS lsqb;GNSrsqb;
机译:Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials
机译:Letter to the editors on ‘Clinical efficacy of lenvatinib for the treatment of radioiodine‐refractory thyroid carcinoma: A systematic review and meta‐analysis of clinical trials’
机译:最小的临床重要差异分析证实了IgPro10在CIDP中的功效:PRIMA试验
机译:最小的临床重要差异分析证实了IgPro10在CIDP中的功效:PRIMA试验